Jason J. Schafer

1.7k total citations · 1 hit paper
42 papers, 1.2k citations indexed

About

Jason J. Schafer is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Jason J. Schafer has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 12 papers in Epidemiology and 12 papers in Emergency Medicine. Recurrent topics in Jason J. Schafer's work include HIV/AIDS drug development and treatment (18 papers), HIV-related health complications and treatments (12 papers) and HIV Research and Treatment (10 papers). Jason J. Schafer is often cited by papers focused on HIV/AIDS drug development and treatment (18 papers), HIV-related health complications and treatments (12 papers) and HIV Research and Treatment (10 papers). Jason J. Schafer collaborates with scholars based in United States. Jason J. Schafer's co-authors include David T. Wong, Christopher A. Schafer, Janice Yoshizawa, James J. Farrell, Bruce J. Paster, Kathleen Squires, Bhavik M. Shah, Debra A. Goff, Joseph DeSimone and Julie E. Mangino and has published in prestigious journals such as Clinical Microbiology Reviews, Vaccine and Obesity.

In The Last Decade

Jason J. Schafer

41 papers receiving 1.2k citations

Hit Papers

Salivary Biomarkers: Towa... 2013 2026 2017 2021 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason J. Schafer United States 16 419 291 222 204 202 42 1.2k
Leïla Belkhir Belgium 18 479 1.1× 88 0.3× 337 1.5× 25 0.1× 202 1.0× 75 1.2k
Norma Jung Germany 21 795 1.9× 136 0.5× 377 1.7× 15 0.1× 601 3.0× 104 2.8k
Jay F. Dobkin United States 19 889 2.1× 103 0.4× 253 1.1× 25 0.1× 516 2.6× 35 1.7k
Sergio Serrano‐Villar Spain 24 1.2k 2.9× 143 0.5× 702 3.2× 31 0.2× 497 2.5× 102 2.4k
Ali Ait Hssain Qatar 18 400 1.0× 145 0.5× 143 0.6× 149 0.7× 313 1.5× 81 1.4k
Daniel Faurholt‐Jepsen Denmark 23 796 1.9× 175 0.6× 158 0.7× 14 0.1× 672 3.3× 127 1.7k
Guglielmo Borgia Italy 31 628 1.5× 82 0.3× 218 1.0× 13 0.1× 1.4k 6.9× 122 2.5k
Jaap ten Oever Netherlands 23 586 1.4× 66 0.2× 205 0.9× 27 0.1× 579 2.9× 89 1.8k
Matti Ristola Finland 23 1.0k 2.5× 105 0.4× 285 1.3× 25 0.1× 690 3.4× 67 2.2k
Roger J. Bulger United States 15 190 0.5× 67 0.2× 117 0.5× 49 0.2× 211 1.0× 56 1.2k

Countries citing papers authored by Jason J. Schafer

Since Specialization
Citations

This map shows the geographic impact of Jason J. Schafer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason J. Schafer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason J. Schafer more than expected).

Fields of papers citing papers by Jason J. Schafer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason J. Schafer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason J. Schafer. The network helps show where Jason J. Schafer may publish in the future.

Co-authorship network of co-authors of Jason J. Schafer

This figure shows the co-authorship network connecting the top 25 collaborators of Jason J. Schafer. A scholar is included among the top collaborators of Jason J. Schafer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason J. Schafer. Jason J. Schafer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akıncıgil, Ayşe, et al.. (2023). Addressing racial inequality and its effects on vaccination rate: A trial comparing a pharmacist and peer educational program (MOTIVATE) in diverse older adults. Journal of Managed Care & Specialty Pharmacy. 29(8). 970–980. 7 indexed citations
2.
Schafer, Jason J., et al.. (2019). 979. BMI and ASCVD Risk Score Changes in Virologically Suppressed Patients with HIV Switching from TDF to TAF Containing ART. Open Forum Infectious Diseases. 6(Supplement_2). S37–S38. 6 indexed citations
3.
DeSimone, Joseph, et al.. (2019). 332. Exploring the Prevalence and Characteristics of Weight Gain and other Metabolic Changes in Patients with HIV Infection Switching to Integrase Inhibitor Containing ART. Open Forum Infectious Diseases. 6(Supplement_2). S176–S177. 13 indexed citations
5.
Schafer, Jason J., et al.. (2019). 338. Patients Living with HIV Infection Are Less Likely to Receive the Correct Intensity of Statin Therapy for Cardiovascular Disease Risk Reduction. Open Forum Infectious Diseases. 6(Supplement_2). S179–S180. 1 indexed citations
6.
Pizzi, Laura T., et al.. (2017). Knowledge, Activation, and Costs of the Pharmacists’ Pneumonia Prevention Program (PPPP): A Novel Senior Center Model to Promote Vaccination. Annals of Pharmacotherapy. 52(5). 446–453. 10 indexed citations
7.
Alcusky, Matthew, et al.. (2015). Cost of a Pharmacist-Led Pneumonia education and immunization program for older Philadelphians. Value in Health. 18(3). A256–A256. 1 indexed citations
8.
Schafer, Jason J., et al.. (2015). Once-Daily, Single-Tablet Regimens For the Treatment of HIV-1 Infection.. PubMed. 40(1). 44–55. 30 indexed citations
9.
Schafer, Jason J., et al.. (2014). Pharmacist Vaccination Programs For Common Infectious Diseases: A Systematic Review Of The Literature On This Emerging Model Of Care. Value in Health. 17(3). A281–A282. 1 indexed citations
10.
Schafer, Christopher A., Jason J. Schafer, Maha Yakob, et al.. (2014). Saliva Diagnostics: Utilizing Oral Fluids to Determine Health Status. Monographs in oral science. 24. 88–98. 87 indexed citations
12.
Schafer, Jason J., et al.. (2013). Bone Health and Human Immunodeficiency Virus Infection. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 33(6). 665–682. 34 indexed citations
13.
Yoshizawa, Janice, Christopher A. Schafer, Jason J. Schafer, et al.. (2013). Salivary Biomarkers: Toward Future Clinical and Diagnostic Utilities. Clinical Microbiology Reviews. 26(4). 781–791. 458 indexed citations breakdown →
14.
Seid, Robert C., et al.. (2012). Transcutaneous immunization with Intercell's vaccine delivery system. Vaccine. 30(29). 4349–4354. 16 indexed citations
15.
Schafer, Jason J.. (2012). A Root Cause Analysis Project in a Medication Safety Course. American Journal of Pharmaceutical Education. 76(6). 116–116. 10 indexed citations
16.
Schafer, Jason J., et al.. (2011). Extended-Spectrum β-Lactamase–Producing Bacterial Infections in Adult Solid Organ Transplant Recipients. Annals of Pharmacotherapy. 45(3). 309–316. 24 indexed citations
17.
Harinstein, Lisa, Jason J. Schafer, & Frank d'Amico. (2011). Risk factors associated with the conversion of meticillin-resistant Staphylococcus aureus colonisation to healthcare-associated infection. Journal of Hospital Infection. 79(3). 194–197. 23 indexed citations
18.
Schafer, Jason J., Debra A. Goff, & Julie E. Mangino. (2009). Doripenem: A New Addition to the Carbapenem Class of Antimicrobials. Recent Patents on Anti-Infective Drug Discovery. 4(1). 18–28. 3 indexed citations
19.
Schafer, Jason J. & Debra A. Goff. (2008). Establishing the role of tigecycline in an era of antimicrobial resistance. Expert Review of Anti-infective Therapy. 6(5). 557–567. 14 indexed citations
20.
Schafer, Jason J., Debra A. Goff, Kurt Stevenson, & Julie E. Mangino. (2007). Early Experience with Tigecycline for Ventilator‐Associated Pneumonia and Bacteremia Caused by Multidrug‐Resistant Acinetobacter baumannii. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(7). 980–987. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026